43.91
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$44.62
Aprire:
$45.22
Volume 24 ore:
5.91M
Relative Volume:
0.29
Capitalizzazione di mercato:
$65.28B
Reddito:
$20.62B
Utile/perdita netta:
$3.56B
Rapporto P/E:
18.41
EPS:
2.3847
Flusso di cassa netto:
$3.48B
1 W Prestazione:
-1.84%
1M Prestazione:
-2.23%
6M Prestazione:
-50.10%
1 anno Prestazione:
-58.01%
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
43.92 | 66.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
ABT
Abbott Laboratories
|
100.08 | 172.14B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
319.26 | 126.97B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
82.83 | 106.96B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
EW
Edwards Lifesciences Corp
|
85.57 | 50.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-30 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific stock trades steadily as Q1 2026 growth and cardiology portfolio underpin valuatio - ad-hoc-news.de
Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Boston Scientific Expands Medical Device R&D in Ireland With €75 Million Investment - Assembly Magazine
Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Boston Scientific stock hits 52-week low at 42.24 USD By Investing.com - Investing.com South Africa
Boston Scientific stock hits 52-week low at 42.24 USD - Investing.com
Boston Scientific (BSX) Faces WATCHMAN Slowdown But Analysts Still See Upside - Yahoo Finance
Why Is Boston Scientific (NYSE:BSX) Growing Medical Technology? - Kalkine Media
Boston Scientific Corp (BSX) Shares Fall 4.5% -- What GF Score o - GuruFocus
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific Slides as WATCHMAN Slowdown Concerns and Fresh Target Cuts Weigh on Shares - Quiver Quantitative
Boston Scientific stock reflects steady medtech demand - ad-hoc-news.de
Disposable Endoscopes Market Size Projected to Hit USD 10.47 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Boston Scientific stock reflects steady growth outlook as medical device demand expands - ad-hoc-news.de
Boston Scientific Corporation (BSX) Is A Stock To Buy According To D. E. Shaw - Yahoo Finance
Daily Brief Health Care: Pharmaron, Ziyond Pharmaceutical, Boston Scientific and more - Smartkarma
Daily Brief United States: Netflix Inc, Autozone Inc, Boston Scientific, Ecolab Inc, Enterprise Products Partners, Global X Uranium ETF, Gold, Harley Davidson, Lennar Corp A, Mohawk Industries and more - Smartkarma
Boston Scientific Top Brass Sued Over Pacemaker Recall - Law360
BN stock holds steady as Boston Scientific grows its medtech base - ad-hoc-news.de
Is Boston Scientific (NYSE:BSX) Due For A Rebound? - Kalkine Media
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? - Yahoo Finance
Prosight Management, LP's Boston Scientific Corp(BSX) Holding History - GuruFocus
Federated Hermes Kaufmann Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Boston Scientific (NYSE:BSX) Climbs As Cardiology Demand Expands - Kalkine Media
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
BSX Maintained by Needham -- Price Target Lowered to $57.00 - GuruFocus
Needham cuts Boston Scientific stock price target on WATCHMAN sales By Investing.com - Investing.com South Africa
Needham cuts Boston Scientific stock price target on WATCHMAN sales - Investing.com
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific focuses on cardiovascular innovation as medical device demand grows - AD HOC NEWS
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MarketWatch
Is Boston Scientific (BSX) Still One of the Best Stocks to Invest In After Jefferies Slashed Its Target? - Yahoo Finance
BSXBoston Scientific Corp Volatility & Greeks - Finviz
Boston Scientific (BSX) Stock Could Be A Bargain After A 57% Slump - Yahoo Finance
Boston Scientific: The Time Has Come To Catch This Falling Knife (NYSE:BSX) - Seeking Alpha
Munro Partners's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Corp. highlights minimally invasive care. Long-term demand supports its medical te - Ad-hoc-news.de
Boston Scientific Corp (NYSE:BSX) Offers Strong Value with High Profitability and Solid Growth - ChartMill
Boston Scientific Announces Software Upgrade for Pacemakers Amid Recall - GuruFocus
BSX Stock | Boston Scientific Corp Q1 2025 Earnings Call Bear Attack (FjRIiYMEgO) - Mshale
Boston Scientific stock hits 52-week low at 61.23 USD - Investing.com
Boston Scientific Corp (BSX) Stock Up 4.8% and Still Undervalued -- GF Score: 74/100 - GuruFocus
Form 4 Boston Scientific Corp For: 2 July By Investing.com - Investing.com India
Boston Scientific (BSX) CFO reports RSU conversion and tax-withheld shares - Stock Titan
Boston Scientific’s Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
Stifel Cuts PT on Boston Scientific Corporation (BSX)- Here’s Why - Insider Monkey
List of 57 Acquisitions by Boston Scientific (Jul 2026) - Tracxn
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):